Table 3.
Stimulant Use by Selected Population Characteristics, 1996, 2002, 2008
| Percent with Use | 1996–2008 Difference |
2002–2008 Difference |
1996–2002 Difference |
||||||
|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||
| 1996 | 2002 | 2008 | t-statistic | p-value | t-statistic | p-value | t-statistic | p-value | |
| Age | |||||||||
| 0–5 | 0.3 (0.1–0.5) | 0.3 (0.0–0.6) | 0.1 (0.0–0.2) | −1.18 | 0.238 | −1.27 | 0.205 | 0.08 | 0.940 |
| 6–12 | 4.2 (3.2–5.2) | 4.8 (3.9–5.6) | 5.1 (4.1–6.1) | 1.29 | 0.197 | 0.54 | 0.591 | 0.89 | 0.373 |
| 13–18 | 2.3 (1.5–3.1) | 3.2 (2.6–3.9) | 4.9 (3.9–6.1) | 3.85 | <.001 | 2.71 | 0.007 | 1.81 | 0.071 |
| Sex | |||||||||
| Male | 3.5 (2.6–4.4) | 4.0 (3.4–4.7) | 5.3 (4.4–6.2) | 2.76 | 0.006 | 2.25 | 0.025 | 0.89 | 0.372 |
| Female | 1.1 (0.7–1.6) | 1.7 (1.3–2.2) | 1.6 (1.1–2.1) | 1.50 | 0.135 | −0.41 | 0.680 | 1.93 | 0.054 |
| Race/Ethnicity (mutually exclusive categories) | |||||||||
| White | 2.9 (2.3–3.6) | 3.6 (3.0–4.2) | 4.4 (3.5–5.2) | 2.53 | 0.012 | 1.34 | 0.180 | 1.46 | 0.144 |
| African American | 1.9 (0.9–3.0) | 2.2 (1.2–3.2) | 3.0 (2.1–3.8) | 1.52 | 0.129 | 1.15 | 0.252 | 0.39 | 0.694 |
| Hispanic | 0.7 (0.3–1.1) | 1.4 (0.9–2.0) | 2.1 (1.5–2.7) | 3.75 | <.001 | 1.63 | 0.103 | 2.16 | 0.031 |
| Other | 0.7 (0.0–1.8) | 1.7 (0.0–3.2) | 1.6 (0.0–3.0) | 0.95 | 0.342 | −0.09 | 0.926 | 0.99 | 0.322 |
| Family income relative to federal poverty line | |||||||||
| Poor/Near Poor (<125%) | 2.1 (1.1–3.0) | 2.6 (1.8–3.4) | 3.6 (2.6–4.7) | 2.27 | 0.023 | 1.62 | 0.106 | 0.88 | 0.380 |
| Low/Middle (125–400%) | 2.4 (1.8–3.1) | 3.2 (2.5–3.8) | 3.3 (2.6–4.0) | 1.79 | 0.074 | 0.30 | 0.767 | 1.58 | 0.115 |
| High Income (>400%) | 2.5(1.5–3.5) | 2.7 (1.9–3.4) | 3.7 (2.5–4.9) | 1.56 | 0.120 | 1.49 | 0.138 | 0.26 | 0.792 |
| Region | |||||||||
| Northeast | 1.8 (1.1–2.5) | 2.7 (1.6–3.9) | 4.6 (3.0–6.1) | 3.22 | 0.001 | 1.88 | 0.060 | 1.49 | 0.138 |
| Midwest | 2.6 (1.3–3.9) | 3.0 (2.0–4.0) | 3.9 (2.8–5.1) | 1.46 | 0.145 | 1.19 | 0.235 | 0.43 | 0.668 |
| South | 3.2 (2.3–4.2) | 3.4 (2.7–4.1) | 4.0 (2.9–5.1) | 1.05 | 0.294 | 0.96 | 0.339 | 0.24 | 0.812 |
| West | 1.2 (0.4–2.0) | 2.2 (1.3–3.1) | 1.6 (1.0–2.1) | 0.71 | 0.477 | −1.18 | 0.239 | 1.65 | 0.100 |
| Urban | |||||||||
| non-MSA | 2.5 (1.6–3.4) | 3.2 (2.3–4.0) | 3.5 (2.2–4.9) | 1.22 | 0.224 | 0.43 | 0.666 | 1.01 | 0.311 |
| MSA | 2.3 (1.7–2.9) | 2.9 (2.4–3.6) | 3.5(2.9–4.1) | 2.71 | 0.007 | 1.69 | 0.092 | 1.31 | 0.191 |
| Insurance | |||||||||
| Any Private | 2.4 (1.9–3.0) | 3.0 (2.5–3.5) | 3.4 (2.7–3.6) | 2.26 | 0.024 | 0.97 | 0.334 | 1.44 | 0.150 |
| Public Only | 3.0 (1.7–4.3) | 3.3 (2.5–4.2) | 4.3 (3.4–5.2) | 1.62 | 0.106 | 1.52 | 0.128 | 0.40 | 0.687 |
| Uninsured | 0.7 (0.1–1.2) | 0.9 (0.0–1.7) | 1.3 (0.0–2.5) | 0.85 | 0.394 | 0.55 | 0.583 | 0.30 | 0.761 |
| Columbia Impairment Scale (ages 5–17) | |||||||||
| Not impaired (CIS< 16) | 2.2 (1.7–2.8) | 2.7 (2.3–3.2) | 3.0 (2.4–3.6) | 1.80 | 0.072 | 0.62 | 0.537 | 1.32 | 0.188 |
| Impaired (CIS>=16) | 10.0 (6.9–13.1) | 13.9 (11.0–16.6) | 18.1 (14.4–21.8) | 3.28 | 0.001 | 1.80 | 0.073 | 1.85 | 0.064 |
Source: Author’s Calculations from the Medical Expenditure Panel Survey (MEPS) 1996–2008
Note: 95 percent confidence intervals in parentheses.